Dr. Subrata Chakravarty, Ph.D.
Chief Scientific Officer
Following a career devoted to research for over 20 years in academia, the pharma/biotech and the nutra-ceutical industry, Dr. Chakravarty joined the Hope4Cancer Treatment Centers team full-time in 2010, where he is today the Chief Scientific Officer and Head of Research & Development. After earning his M.S./Ph.D. degrees from the Indian Agricultural Research Institute, he completed a second Ph.D. in medicinal chemistry from Stony Brook University (New York, USA) where he was involved in the medicinal and computational design of potential drug candidates including taxane chemotherapeutics, as well as antiviral and antithrombotic agents.
Dr. Chakravarty is an excellent researcher, writer, editor and illustrator, with dozens of peer-reviewed papers and four patents to his credit. Being one of the most experienced members of the Hope4Cancer team, he has played a pivotal role in the growth of the company over the years and continues to play an active role in Hope4Cancer’s Leadership Team, contributing to various areas of the company’s management.
Along with his R&D Team, Dr. Chakravarty played a pivotal role in supporting Hope4Cancer’s efforts in researching new therapies, providing avenues for data-driven decision-making, and developing innovative ways to increase patient engagement and education.